A recent meta-analysis review study looked into the association of cholesterol-lowering statin drug use with herpes zoster or shingles outbreaks, and determined there was a strong association of higher risk of shingles for older people who take statin drugs. Herpes zoster, more commonly known as shingles, is a painful skin irritation marked by rows of small sores with tiny blisters. It often strikes people over 50 who have experienced chickenpox during childhood. It’s suspected that this occurs when one’s cellular immune system is lowered enough to allow activating the dormant varicella virus (chicken pox) remaining after an earlier recovery from it. What may appear at first as non-threatening small skin lesions can become painful and more debilitating than chickenpox. This reactivated, more virulent form of varicella virus can damage nerves enough to develop into postherpetic neuralgia, which rephrased in layperson's language is "after herpes came intense nerve pain." Acute and chronic peripheral nerve pain may exist in the areas where the shingles skin lesions are located. The consequences can be lethal.
Experts Review of 107 Scientific Studies: Cholesterol Does Not Cause Heart Disease – Statin Drugs are Useless
A recent massive study review coordinated by 16 medical scholars and practicing MDs throughout England, Ireland, Italy, Japan, Sweden, and the USA has confirmed the falsity of the lipid theory of heart disease that blames cholesterol, and the disinformation and dangers of cholesterol-lowering statin drugs. Its title is LDL-C Does Not Cause Cardiovascular Disease: a comprehensive review of current literature. LDL-C stands for low-density lipoprotein cholesterol, aka the "bad cholesterol". This review was not funded by any government agency, non-government organization, or pharmaceutical company. It was not funded at all.
As the "baby-boomer" generations move into their senior years, they are seen as a "cash-cow" for pharmaceutical companies. For example, it is estimated that about one out of every four Americans over the age of 55 are currently being prescribed cholesterol-lowering statin drugs, in spite of the evidence that these drugs do not prolong lifespans, and have very serious side effects. Studies have confirmed that dementia, especially early onset dementia, is often caused by too many pharmaceutical drugs. A Harvard Medical School publication, "Guide to Coping with Alzheimer's Disease," states: "Medications are common culprits in mental decline. With aging, the liver becomes less efficient at metabolizing drugs, and the kidneys eliminate them from the body more slowly. As a result, drugs tend to accumulate in the body. Elderly people in poor health and those taking several different medications are especially vulnerable." As people age, they wind up taking, on average, more than four prescribed pharmaceutical drugs daily. Many of these medications are for heart disease prevention by lowering cholesterol and also for lowering blood pressure. These drugs are intended to be taken till death. The side effects from those drugs alone can create the need for more prescriptions. The pharmaceutical business model depends on sick customers staying sick, not healing them.
The least publicized actual side effect of cholesterol-lowering statin drugs that complements the dangerous intended effect of reducing cholesterol is they also block CoQ10 production, which is already waning among those aged 40 and older. That’s the age when people begin getting prescribed statins per the newest statin drug guidelines. The irony is that CoQ10 is vital for good heart health! CoQ10 is on high demand from cells in muscle tissue, and the muscle that works the most without rest is the heart. Instead of supplementing CoQ10 when one reaches the 40 year plus mark, he or she will likely be prescribed statin drugs for life as a preventative against cardiovascular disease and heart attack. As statin drugs decrease one’s already lowered CoQ10 production from aging, the heart can get slowly weaker, leading to congestive heart failure. This is when the heart keeps beating, but it is so weak it isn’t strong enough to maintain blood flow throughout to meet the body's needs. Instead of the pain that accompanies a sudden heart attack, gradually one begins to have less and less energy. Excessive tiredness comes in that may be incorrectly attributed to aging or being out of shape. Exercise only further exposes one’s breathing problems. Distended belly and leg swelling also occur. This can go on for years with increasing disability until there is a total heart failure. The newest guidelines for statins almost require physicians to put patients on statins as a preventative practice for life. As the CoQ10 deficiency worsens from statins, the poor patient goes into a debilitating spiral without any recognition to its true cause.
The pharmaceutical empire strikes back. After the recent few years of increasing “statin deniers” getting an occasional mainstream media appearance, vested interest parties are coming up with studies to “prove” statins (cholesterol-lowering drugs) are safe. The problem is most folks on the fence, as most are, will be distracted by these studies no matter how biased and without merit they may be. Doctors who know the truth about statins are forced to pick any such statin safety study apart in response in order to straighten out doctors who prescribe statins based on pharmaceutical reps’ presentations and industry biased studies. One such doctor who is outspokenly critical of statin drugs, Scottish General Practitioner (GP) Malcom Kendrick, M.D., recently focused on a Lancet paper that intended to prove side effects from statin drugs were not only greatly exaggerated, but all in the patients' heads. According to the paper, patients were suffering from the “nocebo effect,” due to all the rising information regarding statin side effect symptoms publicly reported. In addition to his analysis of the study and comparisons to other studies, Dr. Kendrick offers his personal and professional experiences of taking patients off statins and watching them recover from torn or ravaged muscles and early onset dementia, among other side effects. Dr. Kendrick’s father, whose side effects had him wheel chair bound until his doctor-son convinced him to quit taking statins is an example he offered. No nocebo effects had them in such terrible shape that was relieved when they got off statins.
The saturated fat lie is officially exposed now that the British Journal of Sports Medicine, a division of the BMJ (British Medical Journal) emphatically declared: “Saturated fat does not clog the arteries: coronary heart disease is a chronic inflammatory condition, the risk of which can be effectively reduced from healthy lifestyle interventions.” The beginning of this very recent BMJ letter, 31 March 2017, reviewing several mega-studies, states early in their editorial: “Despite popular belief among doctors and the public, the conceptual model of dietary saturated fat clogging a pipe is just plain wrong.” Wrong, unequivocally and indisputably, not maybe or could be or further studies needed, but completely wrong. It’s over. And the root cause of arterial inflammation is cited with dietary recommendations that lean toward the Mediterranean Diet.
Since 2015 there have been a few pharmaceutical companies working on a new cholesterol-lowering drug type as a replacement for the older class of statin drugs, such as Lipitor. Lipitor was the best-selling drug of all time, but its patent expired a few years ago. The new mantra is getting LDL cholesterol levels lower than statin drugs. The drug class of these new cholesterol-lowering drugs is a PCSK9 inhibitor. Of course, this is madness for two reasons: (1) Cholesterol and fats, in general, are not the cause of heart disease; (2) cholesterol is vital for hormone production and nervous system and brain function. The fact is that cholesterol is vitally essential for good health, and lowering cholesterol artificially can and does lead to more immediate health problems, and a lower life expectancy. So why the focus for a new cholesterol-lowering drug? Once again, we follow the money.
The statin or cholesterol reduction drug push has been tagged as the biggest medical scam of all time by medical practitioners who know better and are not afraid of being sued or harassed by drug makers. Despite several peer reviewed published studies that show both the ineffectiveness and dangers of statin drugs, they continue to dominate the pharmaceutical drug market. Cholesterol reducing statin drugs are prescribed unnecessarily and often with serious side effects, even as the whole theory of cholesterol causing heart attacks is proving false. For the thousands of victims filing lawsuits against Lipitor, the top selling cholesterol lowering statin drug of all time, a serious setback was suffered recently when U.S. District Judge Richard Gergel dismissed almost all of the 2800 cases being heard in his court.
Statins are the most profitable medications produced by the Big Pharma Cartel. A report from the National Center for Health Statistics claims that 50% of men age 65-74, and nearly 40% of women over the age of 75 take a statin medication. A 2011 study found over 32 million Americans were taking a statin drug. If that many people are prescribed a drug, one would assume that the drug is effective at treating or preventing something. How effective are statin medications? Not very. This class of medications fails nearly 99% of those who take them. Cardiologists order coronary artery calcium scores to assess how much calcium is deposited in the coronary arteries. This test is done with a computerized tomography (CT) scan. According to the Cleveland Clinic, “Coronary calcium scores are the most sensitive approaches to detecting coronary calcification from atherosclerosis before symptoms develop.” In other words, the higher the coronary artery calcium score, the more risk there is for having a heart attack. An article in The Journal of the American College of Cardiology investigated whether the use of stains influences the progression of coronary artery calcification during five years of follow-up in subjects who took a statin medication and compared them to subjects who did not take a statin drug. The scientists reported that subjects who took statins for five years, when compared to those that took a placebo, were found to have a 2-fold increase in coronary artery calcification progression.
New findings from a large national claims database show the use of cholesterol-lowering statin drugs to be associated with an increased risk for Parkinson's disease (PD), contrary to previous research suggesting the drugs have a protective effect for PD.